Forian Inc. (NASDAQ:FORA) Short Interest Update

Forian Inc. (NASDAQ:FORA) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 179,000 shares, an increase of 8.0% from the March 31st total of 165,700 shares. Currently, 1.2% of the company’s stock are short sold. Based on an average daily volume of 27,300 shares, the days-to-cover ratio is presently 6.6 days.

Hedge Funds Weigh In On Forian

Hedge funds have recently made changes to their positions in the business. Pathstone Family Office LLC bought a new position in shares of Forian during the 3rd quarter worth approximately $39,000. Independent Advisor Alliance boosted its holdings in shares of Forian by 21.2% in the 3rd quarter. Independent Advisor Alliance now owns 22,491 shares of the company’s stock valued at $50,000 after buying an additional 3,936 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Forian by 11.4% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 40,000 shares of the company’s stock valued at $89,000 after buying an additional 4,092 shares during the last quarter. Aufman Associates Inc acquired a new stake in shares of Forian in the 3rd quarter valued at approximately $117,000. Finally, Canton Hathaway LLC boosted its holdings in shares of Forian by 6.8% in the 4th quarter. Canton Hathaway LLC now owns 263,525 shares of the company’s stock valued at $771,000 after buying an additional 16,725 shares during the last quarter. 19.25% of the stock is owned by institutional investors.

Forian Stock Down 0.2 %

Shares of FORA opened at $2.61 on Thursday. The stock has a market capitalization of $81.25 million, a P/E ratio of 7.88 and a beta of 1.03. Forian has a twelve month low of $1.85 and a twelve month high of $4.15. The company has a 50 day moving average of $2.97 and a 200-day moving average of $2.75.

Forian (NASDAQ:FORA) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $5.37 million for the quarter, compared to the consensus estimate of $5.72 million.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm reissued a “buy” rating and set a $5.00 target price on shares of Forian in a research note on Thursday, April 4th.

Forian Company Profile

Forian Inc provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other.